10x Genomics Inc.
TXG
Our mission is to accelerate the mastery of biology to advance human health. We are a life sciences technology company focused on building innovative products and solutions to interrogate, understand and master biology.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$619M
▲ +5.2% YoY
Net Income (TTM)
-$67M
▲ +76.2% YoY
Op. Margin
-11.67%
▲ +22.4pp YoY
ROIC
-6.35%
▲ +13.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$94M
▲ +2371.2% YoY
Op. Cash Flow (TTM)
$100M
▲ +1941.6% YoY
Net Debt
-$500M
Net Cash Position
Cash & Equiv.
$576M
5Y CAGR: +16.6%
Continue Research
Peers
Laboratory Analytical Instruments · Pick stocks to compare with TXG
Held by ETFs
TXG is in 87 US ETFs. The largest of them, with TXG's weight in each:
10x Genomics (TXG) in four numbers
Questions about 10x Genomics
Is 10x Genomics (TXG) overvalued?
At $59.28, 10x Genomics' price is 115% above the $27.54 a share fair value that Intrinsiqq's calculator gets from its revenue. It trades at 82.69 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.
What is 10x Genomics' fair value?
Intrinsiqq's calculator puts 10x Genomics' fair value at $27.54 a share. It grows revenue per share 4.3% a year for 5 years, applies an exit P/S of 7.6, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $20.66. Every input can be changed on the Intrinsic Value tab.
Is 10x Genomics a high-quality business?
10x Genomics scores 48 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 6 checks computed from SEC filings. Its best check is margin trend at +20.8pp, and its weakest is return on capital at -6.3%. The Quality tab shows every check against its target.
Does 10x Genomics (TXG) pay a dividend?
No. 10x Genomics (TXG) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 6 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 6 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in TXG's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing TXG
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.